Efficacy Trial of a Commercial EV71 Vaccine

Status Completed

Clinical Trial Summary

The purpose of this post-marketing study is to evaluate the efficacy, immunogenicity, and safety of the EV71 vaccine post marketing, and explore the protective levels of various enterovirus neutralizing antibodies

Clinical Trial Description

This study is a post-marketing aims to evaluate the efficacy, immunogenicity, and safety of the EV71 vaccine, and explore the protective levels of various enterovirus neutralizing antibodies. This study includes the following three sections: (1) efficacy study of EV71 vaccine based on enhanced cases monitoring, using prospective cohort study design (2) study on correlation between EV71 vaccine protection and EV71 antibody levels, using case-control study design (3) pathogenic spectrum and sero-epidemiological investigation of hand, foot and mouth disease (HFMD) in children. 15500 volunteers aged 6-71 months are expected to participate in this study, among which 5000 volunteers aged 6-35 months will receive two doses EV71 vaccine manufactured by Sinovac Biotech Co., Ltd, and constitute the experimental cohort. 10000 unvaccinated volunteers aged 6-35 months will constitute the the control cohort. The efficacy evaluation will be conducted based on the abovementioned two cohort. Enhanced HFMD surveillance system will be established to report the HFMD cases in the abovementioned 2 cohorts, as well as another cohort consisting of 500 volunteers aged 36-71 months. The case surveillance period of this study is one year. Laboratory tests will be conducted for case confirmation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03903926
Study type	Interventional
Source	Sinovac Biotech Co., Ltd
Contact
Status	Completed
Phase	Phase 4
Start date	March 26, 2019
Completion date	October 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06063057` - Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial	Phase 1/Phase 2
Completed	`NCT04133584` - The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine	Phase 4
Completed	`NCT03241030` - Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial	Phase 2
Completed	`NCT01255124` - Study on Dynamic Changes of the Maternal Anti-EV71 and Anti-CVA16 Antibody Levels in Infants and Young Children	N/A
Completed	`NCT03873740` - Immunogenicity and Safety of Two Different Commercial EV71 Vaccines	Phase 4
Completed	`NCT05637229` - A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia
Recruiting	`NCT06146088` - Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine	Phase 4
Active, not recruiting	`NCT06209398` - Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine	Phase 4
Recruiting	`NCT01175915` - A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease	N/A
Recruiting	`NCT01145664` - A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease	N/A
Completed	`NCT01182532` - A Clinical Trial to Evaluate the Effectiveness and Safety of Chinese Medicine in the Treatment of Mild Type of Hand, Foot, and Mouth Disease	N/A
Completed	`NCT03281174` - Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine	N/A
Completed	`NCT03582761` - Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71	Phase 4
Completed	`NCT02001233` - A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
Completed	`NCT03909074` - Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months	Phase 3
Completed	`NCT01769794` - Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled Study	N/A
Recruiting	`NCT01182025` - A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease	N/A
Recruiting	`NCT06263439` - Surveillance of HFMD in Pediatric Outpatients
Not yet recruiting	`NCT05397587` - An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)	Phase 4
Completed	`NCT04111432` - Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines	Phase 4